Problem: A 33-year-old female patient presents for a follow-up visit for her treatment of social anxiety disorder. She reports minimal improvement in her symptoms with her current prescription of paroxetine after also failing a trial of sertraline. Because both of those medications are in the selective serotonin reuptake inhibitor class, the clinician decides to try an agent from the serotonin and norepinephrine reuptake inhibitor class. Which of the following agents is a serotonin and norepinephrine reuptake inhibitor approved to treat social anxiety disorder? Need Assignment Help? A. Venlafaxine B. Milnacipran C. Duloxetine D. Desvenlafaxine